Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benign and malignant tumors in Rubinstein-Taybi syndrome.
Boot MV, van Belzen MJ, Overbeek LI, Hijmering N, Mendeville M, Waisfisz Q, Wesseling P, Hennekam RC, de Jong D. Boot MV, et al. Among authors: hijmering n. Am J Med Genet A. 2018 Mar;176(3):597-608. doi: 10.1002/ajmg.a.38603. Epub 2018 Jan 23. Am J Med Genet A. 2018. PMID: 29359884 Free PMC article.
Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast.
de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D. de Boer M, et al. JAMA Oncol. 2018 Mar 1;4(3):335-341. doi: 10.1001/jamaoncol.2017.4510. JAMA Oncol. 2018. PMID: 29302687 Free PMC article.
Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs.
de Boer M, van Middelkoop M, Hauptmann M, van der Bijl N, Bosmans JAW, Hendriks-Brouwer N, Schop SJ, de Boer JP, Hijmering NJ, Overbeek LIH, Lobbes MBI, Klazen CAH, de Jong D, Rakhorst HA, van der Hulst RRWJ, van Leeuwen FE. de Boer M, et al. Among authors: hijmering nj. Aesthet Surg J. 2020 Jan 29;40(2):156-164. doi: 10.1093/asj/sjz136. Aesthet Surg J. 2020. PMID: 31242279 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 32898861
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.
van der Horst HJ, de Jonge AV, Hiemstra IH, Gelderloos AT, Berry DRAI, Hijmering NJ, van Essen HF, de Jong D, Chamuleau MED, Zweegman S, Breij ECW, Roemer MGM, Mutis T. van der Horst HJ, et al. Among authors: hijmering nj. Blood Cancer J. 2021 Feb 18;11(2):38. doi: 10.1038/s41408-021-00430-6. Blood Cancer J. 2021. PMID: 33602901 Free PMC article.
21 results